Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Spleen tyrosine kinase (Syk) inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases


  • Please log in to reply
No replies to this topic

#1 CraigR

CraigR

    Senior Silver Member

  • Members
  • PipPipPipPipPip
  • 438 posts
  • Location:Escondido (near San Diego), Ca

Posted 24 February 2011 - 02:55 AM

Spleen tyrosine kinase (Syk) inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases. Preclinical studies presented compelling evidence that Syk inhibition may have therapeutic value in the treatment of rheumatoid arthritis and other forms of arthritis, systemic lupus erythematosus, autoimmune cytopenias, and allergic and autoinflammatory diseases. Pamuk ON Arthritis Res Ther. 2010 Dec 17;12(6):222. (UnboundMedline) (Also see: Autoimmunity)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Craig Roothoff
ISN Assistant News Guide
International Scleroderma Network(ISN)